EIF3A and neoplasm: YTHDF3 is highly expressed in OX-resistant CRC tissues and recognizes the 5′-UTR of m6A-methylated RNAs associated with tumor resistance, and recruiting eukaryotic translation initiation factor 3 subunit A (eIF3A) to promote translation of drug-resistant genes (Zhao et al. 2022).